DCPH - Jones Research upgrades Deciphera to buy from hold
2023-10-31 13:49:23 ET
More on Deciphera Pharmaceuticals
- Deciphera Pharmaceuticals Pipeline Is Underwhelming
- Deciphera Pharmaceuticals: Clawing Its Way Back
- Deciphera Pharmaceuticals, Inc. (DCPH) Q2 2023 Earnings Call Transcript
- Deciphera stock climbs as trial for tumor therapy succeeds (update)
- Seeking Alpha’s Quant Rating on Deciphera Pharmaceuticals
For further details see:
Jones Research upgrades Deciphera to buy from hold